COMMUNIQUÉS West-GlobeNewswire

TAP Sleep Care® Combination Therapy Delivers 95% AHI Reduction in Severe CPAP-Resistant OSA
11/08/2026
Dr. Martin A. Denbar’s clinical case series documents interfaced therapy using TAP-PAP interface with TAP oral appliance DALLAS, Aug. 11, 2026 (GLOBE NEWSWIRE) -- TAP Sleep Care ® today highlighted clinical evidence on [...]
Zus Health Achieves HITRUST r2 Certification, Demonstrating Commitment to Cybersecurity and Information Protection
11/08/2026
BOSTON, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Zus Health , the healthcare data platform that unifies scattered data into an always-on common patient record, today announced that its shared FHIR-native platform residing at [...]
Vor Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update
11/08/2026
Enrollment on track for Phase 3 UPSTREAM MG trial of telitacicept in generalized myasthenia gravis patients with topline results anticipated in 1H27 Enrollment ongoing for Phase 3 UPSTREAM SjD of telitacicept in primary [...]
Microbot Medical® Files 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second Quarter
11/08/2026
Revenue increased by more than 100% over the prior fiscal quarter, driven by repeat orders, expanded utilization among existing customers, and the acquisition of new customers since the Full Market Release in mid-April [...]
Longeveron Named a Finalist Team and Will Receive a $1,000,000 Milestone 2 Award for the XPRIZE Healthspan Global Competition
11/08/2026
Longeveron selected as a Milestone 2 Awardee based on published clinical trial results which demonstrated laromestrocel increased 6-minute walk distance in patients with Aging-related Frailty MIAMI, Aug. 11, 2026 (GLOBE [...]
Hi*Ball® Energy Powers into the English Football League with Wolverhampton Wanderers Partnership
11/08/2026
English Football League partnership expands Hi*Ball’s UK presence, bringing the clean, zero-sugar sparkling energy brand to one of football’s most passionate fanbases LONDON, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Hi*Ball [...]
Wandercraft Receives FDA Clearance for Eve, the World’s First Self-Balancing Personal Exoskeleton, for Eligible Wheelchair Users Living with Spinal Cord Injuries at Any Level
11/08/2026
Clearance opens a new category of self-balancing robotics for people living with severe mobility disabilities and advances Eve toward commercial launch within established Medicare reimbursement pathway NEW YORK, Aug. 11 [...]
Vivos Therapeutics Expands Greenway Health Partnership to Deploy AI-Enabled Platform Across All Clinical and Revenue Operations
11/08/2026
Greenway analysis estimates AI-enabled automation in Nevada alone could create up to $9.0 million in potential annual value, including approximately $8.0 million from increased patient capacity and $1.0 million from [...]
Intelligent Bio Solutions Announces Completion of Method Comparison Study for the Intelligent Fingerprinting Drug Screening System
11/08/2026
All clinical data collection across the Company's FDA 510(k) clinical study program is complete; FDA submission on track for second half of 2026 NEW YORK, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc [...]
RenovoRx Achieves Major Milestone with Full Enrollment in Phase III TIGeR-PaC Trial for Locally Advanced Pancreatic Cancer
11/08/2026
Completion of Trial Expected in First Half 2027 With Topline Data Readout Expected Second Half 2027 MOUNTAIN VIEW, Calif., Aug. 11, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or “the Company”) (Nasdaq: RNXT) , [...]
Conexeu to Present at 2026 Controversies & Conversations in Laser & Cosmetic Surgery Symposium on the Role of the Extracellular Matrix in Tissue Regeneration
11/08/2026
RENO, Nev., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Conexeu Sciences Inc. (Nasdaq: CNXU) ("Conexeu" or the "Company"), a preclinical-stage biotechnology company advancing an investigational tissue-restoration platform, [...]
Cingulate Publishes Peer-Reviewed Data Demonstrating CTx-1301’s Differentiated Pharmacokinetic Profile
11/08/2026
Findings further validate Cingulate’s Precision Timed Release™ (PTR™) platform and its trimodal drug delivery approach KANSAS CITY, Kan., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a [...]
Achieve Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Updates
11/08/2026
Closed a private placement of up to $354 million, with $180 million upfront and up to $174 million from warrants exercisable prior to and up to 20 trading days following FDA approval Strengthened organization with new [...]
Introducing Veritas24-7™ – A New Way for Pharmaceutical Companies to Engage Physicians 24 Hours a Day
11/08/2026
Through lifelike AI personas, Veritas24-7 provides physicians with immediate 24 hours a day access to company-approved Medical Science Liaison and Sales Representative expertise through natural, face-to-face, two-way [...]
PDS Biotech Announces Strategic Refocus Prioritizing PDS0301 in Metastatic Colorectal Cancer (mCRC) and Partnership Strategy for PDS0101
11/08/2026
PDS0301 Phase 2 clinical data in mCRC and a comprehensive review of capital allocation priorities drive strategic refocus designed to maximize long-term shareholder value PRINCETON, N.J., Aug. 11, 2026 (GLOBE NEWSWIRE [...]
Mereo BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Highlights
11/08/2026
Entered into option and license agreement with Sentynl Therapeutics for alvelestat, Mereo’s investigational oral therapy for Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD) Mereo and partner Ultragenyx [...]
Flyte Partners with The Nucleus Network for Inaugural Flagship Founder & Investor Event
11/08/2026
Strategic Partnership Places Flyte at the Center of One of the Nation's Premier Communities of Founders, Investors, and Operators Collaboration Reflects Flyte's Continued Commitment to Building Relationships Within the [...]
Clearmind Medicine Announces Positive Permeation Results for Intranasal MEAI Formulation, Supporting Enhanced Nasal Retention Without Compromising Drug Delivery
11/08/2026
Vancouver, Canada, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND, FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, [...]
Moody’s Ratings Upgrades Teva to Investment Grade, Reflecting the Ongoing Execution of Pivot to Growth Strategy
11/08/2026
TEL AVIV, Israel, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Moody’s Ratings has upgraded Teva’s corporate credit rating to Baa3 from Ba1, an [...]

Pages